Page last updated: 2024-11-12

8-epipuupehedione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

8-epipuupehedione: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10042061
CHEMBL ID5207547
MeSH IDM0460395

Synonyms (3)

Synonym
8-epipuupehedione
(4as,6ar,12bs)-4,4,6a,12b-tetramethyl-1,2,3,4a,5,6-hexahydrobenzo[a]xanthene-9,10-dione
CHEMBL5207547
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1876440Antifungal activity against Rhizoctonia solani at 150 uM2022European journal of medicinal chemistry, Jan-05, Volume: 227Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.
AID1876442Antifungal activity against Pyricularia oryzae at 150 uM2022European journal of medicinal chemistry, Jan-05, Volume: 227Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.
AID1876439Antifungal activity against Sclerotinia sclerotiorum at 150 uM2022European journal of medicinal chemistry, Jan-05, Volume: 227Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.
AID1876443Antifungal activity against Phytophthora capsici at 150 uM2022European journal of medicinal chemistry, Jan-05, Volume: 227Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.
AID1876441Antifungal activity against Fusarium graminearum at 150 uM2022European journal of medicinal chemistry, Jan-05, Volume: 227Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]